Detecting contamination events during robotic total joint arthroplasty - 15/08/24
Résumé |
Background |
Robot-assisted total joint arthroplasty (robotic-TJA) has become more widespread over the last 20 years due to higher patient satisfaction and reduced complications. However, robotic TJA may have longer operative times and increased operating room traffic, which are known risk factors for contamination events. Contamination of surgical instruments may be contact- or airborne-related with documented scalpel blade contamination rates up to 9%. The robot arm is a novel instrument that comes in and out of the surgical field, so our objective was to assess whether the robot arm is a source of contamination when used in robotic TJA compared to other surgical instruments.
Methods |
This was a prospective, single-institution, single-surgeon pilot study involving 103 robotic TJAs. The robot arm was swabbed prior to incision and after closure. Pre- and postoperative control swabs were also collected from the suction tip and scalpel blade. Swabs were incubated for 24 hours on tryptic soy agar followed by inspection for growth of any contaminating bacteria.
Results |
A contamination event was detected in 10 cases (10%). The scalpel blade was the most common site of contamination (8%) followed by the robot arm (2%) and suction tip (0%).
Discussion |
Robotic TJA is contaminated with bacteria at a rate around 10%. Although the robot arm is an additional source of potential contamination, the robot arm accrues bacterial contamination infrequently compared to the scalpel blade.
Conclusion |
Contamination of the robot arm during robotic TJA is minimal when compared to contamination of the scalpel blade.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Contamination during robotic total joint arthroplasty occurs at a rate up to 10%. |
• | There is minimal contamination of the robot arm during robotic TJA. |
• | The scalpel was the most common site of perioperative contamination. |
Key Words : Bacteria, Robot-arm, Scalpel, Hip replacement, Knee replacement
Plan
Conflicts of interest: DFA reports grants from NIH-NCATS and OREF, consultancy for DePuy, Exactech, Medacta, United Orthopedics, and Stryker, patents owned by Arthology Consulting, Knimble Designs, nSight Surgical, PlantarTech, and Stanford University, royalties from Exactech, and stock/stock options in nSight Surgical, Knimble Designs, WellBeam, QT Ultrasound, and Recoup Fitness, all unrelated to the submitted work. All other authors (JJL, KO, AF, RM) have no conflicts to report. |
|
Funding/support: Dr Amanatullah was supported by the NIH-NCATS KL2 Award (KL2TR003143) during the time of this study. The content is solely the responsibility of the authors and does not reflect the official views of the NIH. These funding sources had no role in the study design, data collection, analysis, interpretation of data, writing the report, or the decision to submit the findings for publication. |
Vol 52 - N° 9
P. 1025-1029 - septembre 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?